SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 2nd, 2006 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is entered into and dated as of June 1, 2006 among Generex Biotechnology Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, a “Purchaser” and collectively, the “Purchasers”).
Amendment to Jan 23 06 Warrant - Amendment to Feb 28 06 WarrantGenerex Biotechnology Corp • June 2nd, 2006 • Pharmaceutical preparations
We make reference to (a) the common stock purchase warrant (the “January Warrant”) issued by Generex Biotechnology Corporation (the “Company”) to (“___________”) on January 23, 2006 pursuant to which the Company granted to ______________ the entitlement to purchase up to ____________ shares of the Company’s common stock at $1.60 per share, and (b) the common stock purchase warrant (the “February Warrant”) issued by the Company to ___________ on February 28, 2006 pursuant to which the Company granted to Cranshire the entitlement to purchase up to __________ shares of the Company’s common stock at $1.25 per share (together, the “Warrants”).
